Johnson & Johnson pauses COVID-19 vaccine trial over patient exhibiting an ‘unexplained illness’

1 min read

The company released a statement on Monday, saying “We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 Ensemble trial, due to an unexplained illness in a study participant.”

The study aimed to test 60,000 participants across the US, Argentina, Brazil and several other countries.

In September, pharmaceutical company AstraZeneca paused clinical trials of an experimental COVID-19 vaccine after a participant in the UK had an unexplained illness, but the study has since resumed in the country.

Johnson & Johnson is in the third and final stage of its trial.

Daily Planet

Stories published by the Daily Planet are either guest pieces, press releases, articles from outside news sources and/or content that was sent to us.

Leave a Reply

Previous Story

US reports over 50,000 new COVID cases per day, highest since mid-August

Latest from Health

%d bloggers like this: